Organigram Wins KIND Magazine’s Cannabis Company of the Year Award and Most Innovative Product of the Year for Edison JOLTS
December 08 2022 - 06:00AM
Business Wire
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
company of a leading licensed producer of cannabis (the “Company”
or “Organigram”), is pleased to announce it has won KIND Magazine’s
(“KIND”) Cannabis Company of the Year award. Considered KIND’s
marquee award, Cannabis Company of the Year is presented to the
licensed producer that the KIND editorial team believes
demonstrates the best combination of people, purpose and product in
a given year.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20221208005310/en/
CEO Beena Goldenberg with the Organigram
team at the KIND Awards (Photo: Business Wire)
“We are very proud to be recognized by KIND Magazine,” says
Beena Goldenberg, CEO, Organigram. “The Cannabis Company of the
Year award is particularly special because it not only acknowledges
Organigram as a top performing licensed producer, but also
celebrates the high-quality of our talented employees from
coast-to-coast. Likewise, the award is unique as it considers
‘purpose’, recognizing Organigram’s commitment to doing good in the
communities we serve.”
In addition to the Cannabis Company of the Year award, the
Company’s Edison Cannabis Co. brand’s Edison JOLTS, Canada’s first
high-potency lozenge, received the Most Innovative Product of the
Year. This award is voted on by budtenders and retail owners from
across Canada.
“We are excited to receive these accolades from some of the most
influential voices in the industry, including both the KIND
editorial team and our industry’s retailers and budtenders,” says
Eric Williams, Senior Director of Marketing, Organigram. “We share
KIND’s commitment to making cannabis a part of Canadian culture and
are proud to be recognized by the hard-working retailers and
talented budtenders who bring their expertise and passion to
support Canadians’ experience of our products every day.”
Organigram was nominated in two other categories including Hash
of the Year for the Company’s Tremblant Hash and CBD Brand of the
Year for its wellness brand, Monjour.
“It felt great to select Organigram for our KIND Cannabis
Company of the Year because they do everything with love — you just
know it's a company that cares for our community,” says Joshua
Nagel, Founder & Chief Dream Officer at KIND. “They had an
impressive year, both from a financial and market share growth
perspective, and have also built beloved consumer brands including
Edison, SHRED and Big Bag o’ Buds, but that's just the half of it.
They're also great human beings to work with and we were impressed
with their commitment to helping their local communities:
Organigram is the kind of company that makes all of us at KIND
happy to be working in weed.”
For more information about Organigram or its brands, please
visit organigram.ca.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include:
Organigram Inc. and Laurentian Organic Inc., licensed producers of
cannabis and cannabis-derived products in Canada, and The Edibles
and Infusions Corporation, a licensed manufacturer of
cannabis-infused edibles in Canada.
Organigram is focused on producing high-quality, cannabis for
patients and adult recreational consumers, as well as developing
international business partnerships to extend the Company’s global
footprint. Organigram has also developed and acquired a portfolio
of legal adult-use recreational cannabis brands, including Edison,
Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Holy Mountain, Wo La,
Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates
facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec,
with a dedicated edibles manufacturing facility in Winnipeg,
Manitoba. The Company is regulated by the Cannabis Act and the
Cannabis Regulations (Canada).
Forward-Looking Information
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
changes to market conditions and consumer preferences, and factors
and risks as disclosed in the Company’s most recent annual
information form, management’s discussion and analysis and other
Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221208005310/en/
For Investor Relations enquiries: investors@organigram.ca
For Media enquiries: Paolo De Luca paolo.deluca@organigram.ca
Chief Strategy Officer, Organigram
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Feb 2023 to Mar 2023
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2022 to Mar 2023